Wird geladen...
Vilanterol and fluticasone furoate for asthma
BACKGROUND: Vilanterol (VI) is a long‐acting beta(2)‐agonist (LABA) that binds to the beta(2)‐adrenoceptor on the airway smooth muscle, producing bronchodilation. LABA therapy, which is well established in adults as part of the British Thoracic Society (BTS) Guidelines for the Management of Asthma,...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2016
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6472525/ https://ncbi.nlm.nih.gov/pubmed/27582089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010758.pub2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|